Latest Prescription Drugs news
Lecanemab-Labeled Amyloid Plaques Identified in Down Syndrome
posted August 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms
posted August 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Olaparib Monotherapy Yields Good PSA Response Rates in Prostate Cancer
posted August 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Socially, Economically Disadvantaged Communities Lack Access to Buprenorphine
posted August 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
